Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis
Open Access
- 1 January 2021
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 12
Abstract
Information on coronavirus disease 2019 (COVID-19) infection in patients with chronic kidney disease (CKD) remains limited. To understand the influence of COVID-19 infection in patients with pre-existing CKD, we conducted a systematic review and meta-analysis to evaluate and compare the risks of all-cause mortality, hospitalization, and critical progression between patients with and without CKD. We selected randomized controlled trials (RCTs), prospective or retrospective observational, case-control, cross-sectional, and case-series studies analyzing outcomes of COVID-19 infection in patients with pre-existing CKD from the PubMed, Embase, and Cochrane Central Register of Controlled Trials databases published on the Internet before 16 July 2020. A total of 27 studies comprising 77,856 patients with COVID-19 infection was identified; 3922 patients with pre-existing CKD were assigned CKD group, and 73,934 patients were assigned to the non-CKD group. The pooled analysis showed that patients with CKD had a significantly higher risk of all-cause mortality and hospitalization than those without CKD [odds ratio (OR) 2.25, 95% confidence interval (CI) 1.91–2.66, p < 0.001; OR 4.29, 95% CI 2.93–6.28, p < 0.001; respectively]. Patients with CKD had a higher risk of critically ill conditions than those without CKD in the pooled analysis of studies with multivariable adjustment (adjusted OR 2.12, 95% CI 0.95–4.77, p = 0.07) and in the analysis of all included studies (OR 1.27, 95% CI 0.71–2.26, p = 0.41), but both analyses did not attain statistical significance. COVID-19 infected patients with CKD had significantly increased risks of all-cause mortality and hospitalization compared with those without CKD.Keywords
Funding Information
- the Ministry of Science & Technology in Taiwan (MOST 109-2314-B-002-150-MY3)
This publication has 47 references indexed in Scilit:
- The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort studyBMC Nephrology, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaborationBMJ, 2015
- Immune cell dysfunction and inflammation in end-stage renal diseaseNature Reviews Nephrology, 2013
- CKD impairs barrier function and alters microbial flora of the intestineCurrent Opinion in Nephrology and Hypertension, 2012
- Acute Respiratory Distress SyndromeJAMA, 2012
- Monocyte subpopulations and cardiovascular risk in chronic kidney diseaseNature Reviews Nephrology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Acute renal impairment in coronavirus-associated severe acute respiratory syndromeKidney International, 2005
- B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2Nephrology Dialysis Transplantation, 2000